EMCITATE 350 microgrammes, comprimé dispersible — plaquette(s) PVC aluminium de 60 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930310700
  • CIP7 3031070
  • CIS 68773605
  • Registration number EU/1/24/1897

What the source publishes

Holder
RARE THYROID THERAPEUTICS INTERNATIONAL AB (SUEDE)
Active ingredients
TIRATRICOL
Form
comprimé dispersible
Package
plaquette(s) PVC aluminium de 60 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services NEUROLOGIE ; prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription hospitalière ; liste I ; prescription réservée aux spécialistes et services GENETIQUE MEDICALE ; prescription réservée aux spécialistes en ENDOCRINOLOGIE - DIABETOLOGIE - NUTRITION
Marketing status
Déclaration de commercialisation
Authorised on
2025-02-12
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930310700
{
  "cis": "68773605",
  "cip7": "3031070",
  "form": "comprimé dispersible",
  "name": "EMCITATE 350 microgrammes, comprimé dispersible — plaquette(s) PVC aluminium de 60 comprimé(s)",
  "cip13": "3400930310700",
  "holder": "RARE THYROID THERAPEUTICS INTERNATIONAL AB (SUEDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "RARE THYROID THERAPEUTICS INTERNATIONAL AB (SUEDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2025-02-12",
  "compositions": [
    {
      "name": "TIRATRICOL",
      "nature": "SA",
      "strength": "350 microgrammes",
      "linkageNumber": "1",
      "substanceCode": "03037",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services NEUROLOGIE ; prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription hospitalière ; liste I ; prescription réservée aux spécialistes et services GENETIQUE MEDICALE ; prescription réservée aux spécialistes en ENDOCRINOLOGIE - DIABETOLOGIE - NUTRITION",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "EMCITATE 350 microgrammes, comprimé dispersible",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) PVC aluminium de 60 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2025-05-15",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "TIRATRICOL"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services NEUROLOGIE",
    "prescription réservée aux spécialistes et services PEDIATRIE",
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux spécialistes et services GENETIQUE MEDICALE",
    "prescription réservée aux spécialistes en ENDOCRINOLOGIE - DIABETOLOGIE - NUTRITION"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/24/1897",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930310700"